InvestorsHub Logo
Followers 8
Posts 481
Boards Moderated 0
Alias Born 02/03/2021

Re: stockorus post# 173229

Tuesday, 07/06/2021 4:23:14 PM

Tuesday, July 06, 2021 4:23:14 PM

Post# of 232969
Dr. Patterson is engaging in back and forth on twitter:



Good to have his side of things; but personally I would prefer he did not do this; he is dragging himself in the mud unnecessarily. Perhaps just make an independent tweet or two on your side of things clarifying your role and position on Leronlimab, then stay quiet as this thing plays out. By getting into management conflict, he is wading into waters where the "scientist" image is not pristine. If he was desperately in favor of Leronlimab saving lives, he could have joined the likes of Dr. Lalezari and shown consistent support through the past stormy months. Mostly he was silent and promoting another drug and protocols while suppressing mention of LL. Now suddenly too much talk does not give a clean impression nor is it suddenly going to make new investors (or medical community) turn to LL. imo.

Edit: perhaps if it turns new investors to LL because Dr. P is talking more of it, then that is a good thing for us. But I doubt people are going to see his messaging independently of his siding with 13-D and as a pure science take.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News